Chlorotrianisene - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlorotrianisene and what is the scope of freedom to operate?
Chlorotrianisene
is the generic ingredient in two branded drugs marketed by Banner Pharmacaps and Sanofi Aventis Us, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for chlorotrianisene.
Summary for chlorotrianisene
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 4 |
Drug Master File Entries: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Clinical Trials: | 1 |
Patent Applications: | 2,667 |
Formulation / Manufacturing: | see details |
DailyMed Link: | chlorotrianisene at DailyMed |
Recent Clinical Trials for chlorotrianisene
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for chlorotrianisene
US Patents and Regulatory Information for chlorotrianisene
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TACE | chlorotrianisene | CAPSULE;ORAL | 008102-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | TACE | chlorotrianisene | CAPSULE;ORAL | 016235-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Banner Pharmacaps | CHLOROTRIANISENE | chlorotrianisene | CAPSULE;ORAL | 084652-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |